Comparisons of direct and indirect utilities in adult epilepsy populations: A systematic review

Emma Foster, Zhibin Chen, Richard Ofori-Asenso, Richard Norman, Patrick Carney, Terence J. O'Brien, Patrick Kwan, Danny Liew, Zanfina Ademi

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Objective: Epilepsy is common and carries substantial morbidity, and therefore identifying cost-effective health interventions is essential. Cost-utility analysis is a widely used method for such analyses. For this, health conditions are rated in terms of utilities, which provide a standardized score to reflect quality of life. Utilities are obtained either indirectly using quality of life questionnaires, or directly from patients or the general population. We sought to describe instruments used to estimate utilities in epilepsy populations, and how results differ according to methods used. Methods: We undertook a systematic review of studies comparing at least two instruments for obtaining utilities in epilepsy populations. MEDLINE, Embase, ScienceDirect, Cochrane Library, Google Scholar, and gray literature were searched from inception to June 2019. Mean utilities were recorded and compared for each method. Results: Of the 38 unique records initially identified, eight studies met inclusion criteria. Utilities were highest for direct "tradeoff" methods, obtained via instruments including standard gamble (0.93) and time tradeoff (0.92), compared to indirect methods, obtained via instruments including EuroQoL five-dimensional form (range = 0.72-0.86) and Health Utilities Index Mark 3 (range = 0.52-0.71). Visual analog scale (VAS), a direct "nontradeoff" instrument, provided equal or lower utilities (range = 68.0-79.8) compared to indirect instruments. Significance: Direct methods, with the important exception of VAS, may provide higher utilities than indirect methods. More studies are needed to identify the most appropriate utility instruments for epilepsy populations, and to investigate whether there is variation between utilities for different types of epilepsy and other patient- and disease-specific factors.

Original languageEnglish
Pages (from-to)2466-2476
Number of pages11
JournalEpilepsia
Volume60
DOIs
Publication statusPublished - 30 Nov 2019

Keywords

  • cost-utility analysis
  • health economics
  • health policy and practice
  • quality of life

Cite this

@article{598540abe923480b8247ee19db5f0cff,
title = "Comparisons of direct and indirect utilities in adult epilepsy populations: A systematic review",
abstract = "Objective: Epilepsy is common and carries substantial morbidity, and therefore identifying cost-effective health interventions is essential. Cost-utility analysis is a widely used method for such analyses. For this, health conditions are rated in terms of utilities, which provide a standardized score to reflect quality of life. Utilities are obtained either indirectly using quality of life questionnaires, or directly from patients or the general population. We sought to describe instruments used to estimate utilities in epilepsy populations, and how results differ according to methods used. Methods: We undertook a systematic review of studies comparing at least two instruments for obtaining utilities in epilepsy populations. MEDLINE, Embase, ScienceDirect, Cochrane Library, Google Scholar, and gray literature were searched from inception to June 2019. Mean utilities were recorded and compared for each method. Results: Of the 38 unique records initially identified, eight studies met inclusion criteria. Utilities were highest for direct {"}tradeoff{"} methods, obtained via instruments including standard gamble (0.93) and time tradeoff (0.92), compared to indirect methods, obtained via instruments including EuroQoL five-dimensional form (range = 0.72-0.86) and Health Utilities Index Mark 3 (range = 0.52-0.71). Visual analog scale (VAS), a direct {"}nontradeoff{"} instrument, provided equal or lower utilities (range = 68.0-79.8) compared to indirect instruments. Significance: Direct methods, with the important exception of VAS, may provide higher utilities than indirect methods. More studies are needed to identify the most appropriate utility instruments for epilepsy populations, and to investigate whether there is variation between utilities for different types of epilepsy and other patient- and disease-specific factors.",
keywords = "cost-utility analysis, health economics, health policy and practice, quality of life",
author = "Emma Foster and Zhibin Chen and Richard Ofori-Asenso and Richard Norman and Patrick Carney and O'Brien, {Terence J.} and Patrick Kwan and Danny Liew and Zanfina Ademi",
year = "2019",
month = "11",
day = "30",
doi = "10.1111/epi.16396",
language = "English",
volume = "60",
pages = "2466--2476",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "John Wiley & Sons",

}

Comparisons of direct and indirect utilities in adult epilepsy populations : A systematic review. / Foster, Emma; Chen, Zhibin; Ofori-Asenso, Richard; Norman, Richard; Carney, Patrick; O'Brien, Terence J.; Kwan, Patrick; Liew, Danny; Ademi, Zanfina.

In: Epilepsia, Vol. 60, 30.11.2019, p. 2466-2476.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Comparisons of direct and indirect utilities in adult epilepsy populations

T2 - A systematic review

AU - Foster, Emma

AU - Chen, Zhibin

AU - Ofori-Asenso, Richard

AU - Norman, Richard

AU - Carney, Patrick

AU - O'Brien, Terence J.

AU - Kwan, Patrick

AU - Liew, Danny

AU - Ademi, Zanfina

PY - 2019/11/30

Y1 - 2019/11/30

N2 - Objective: Epilepsy is common and carries substantial morbidity, and therefore identifying cost-effective health interventions is essential. Cost-utility analysis is a widely used method for such analyses. For this, health conditions are rated in terms of utilities, which provide a standardized score to reflect quality of life. Utilities are obtained either indirectly using quality of life questionnaires, or directly from patients or the general population. We sought to describe instruments used to estimate utilities in epilepsy populations, and how results differ according to methods used. Methods: We undertook a systematic review of studies comparing at least two instruments for obtaining utilities in epilepsy populations. MEDLINE, Embase, ScienceDirect, Cochrane Library, Google Scholar, and gray literature were searched from inception to June 2019. Mean utilities were recorded and compared for each method. Results: Of the 38 unique records initially identified, eight studies met inclusion criteria. Utilities were highest for direct "tradeoff" methods, obtained via instruments including standard gamble (0.93) and time tradeoff (0.92), compared to indirect methods, obtained via instruments including EuroQoL five-dimensional form (range = 0.72-0.86) and Health Utilities Index Mark 3 (range = 0.52-0.71). Visual analog scale (VAS), a direct "nontradeoff" instrument, provided equal or lower utilities (range = 68.0-79.8) compared to indirect instruments. Significance: Direct methods, with the important exception of VAS, may provide higher utilities than indirect methods. More studies are needed to identify the most appropriate utility instruments for epilepsy populations, and to investigate whether there is variation between utilities for different types of epilepsy and other patient- and disease-specific factors.

AB - Objective: Epilepsy is common and carries substantial morbidity, and therefore identifying cost-effective health interventions is essential. Cost-utility analysis is a widely used method for such analyses. For this, health conditions are rated in terms of utilities, which provide a standardized score to reflect quality of life. Utilities are obtained either indirectly using quality of life questionnaires, or directly from patients or the general population. We sought to describe instruments used to estimate utilities in epilepsy populations, and how results differ according to methods used. Methods: We undertook a systematic review of studies comparing at least two instruments for obtaining utilities in epilepsy populations. MEDLINE, Embase, ScienceDirect, Cochrane Library, Google Scholar, and gray literature were searched from inception to June 2019. Mean utilities were recorded and compared for each method. Results: Of the 38 unique records initially identified, eight studies met inclusion criteria. Utilities were highest for direct "tradeoff" methods, obtained via instruments including standard gamble (0.93) and time tradeoff (0.92), compared to indirect methods, obtained via instruments including EuroQoL five-dimensional form (range = 0.72-0.86) and Health Utilities Index Mark 3 (range = 0.52-0.71). Visual analog scale (VAS), a direct "nontradeoff" instrument, provided equal or lower utilities (range = 68.0-79.8) compared to indirect instruments. Significance: Direct methods, with the important exception of VAS, may provide higher utilities than indirect methods. More studies are needed to identify the most appropriate utility instruments for epilepsy populations, and to investigate whether there is variation between utilities for different types of epilepsy and other patient- and disease-specific factors.

KW - cost-utility analysis

KW - health economics

KW - health policy and practice

KW - quality of life

UR - http://www.scopus.com/inward/record.url?scp=85075984793&partnerID=8YFLogxK

U2 - 10.1111/epi.16396

DO - 10.1111/epi.16396

M3 - Article

C2 - 31784994

AN - SCOPUS:85075984793

VL - 60

SP - 2466

EP - 2476

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

ER -